Microbix Biosystems Inc.
MBXBF
$0.19
$0.00-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.96M | 13.26M | 15.15M | 16.34M | 16.81M |
| Total Other Revenue | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Revenue | 11.96M | 13.26M | 15.15M | 16.34M | 16.81M |
| Cost of Revenue | 6.39M | 6.24M | 6.71M | 6.91M | 7.39M |
| Gross Profit | 5.58M | 7.01M | 8.44M | 9.43M | 9.42M |
| SG&A Expenses | 6.48M | 6.44M | 6.33M | 6.28M | 6.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.50M | 14.34M | 14.68M | 14.82M | 15.07M |
| Operating Income | -2.54M | -1.09M | 469.70K | 1.52M | 1.74M |
| Income Before Tax | -3.13M | -1.68M | -127.50K | 1.24M | 1.51M |
| Income Tax Expenses | -40.50K | -40.50K | 110.40K | 110.40K | 110.40K |
| Earnings from Continuing Operations | -3.09 | -1.64 | -0.24 | 1.13 | 1.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.09M | -1.64M | -237.90K | 1.13M | 1.40M |
| EBIT | -2.54M | -1.09M | 469.70K | 1.52M | 1.74M |
| EBITDA | -1.39M | 111.30K | 1.46M | 2.51M | 2.72M |
| EPS Basic | -0.02 | -0.01 | 0.00 | 0.01 | 0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | 0.00 | 0.01 | 0.01 |
| EPS Diluted | -0.02 | -0.01 | 0.00 | 0.01 | 0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | 0.00 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 555.70M | 551.56M | 555.65M | 551.91M | 549.44M |
| Average Diluted Shares Outstanding | 556.50M | 552.99M | 557.83M | 554.85M | 553.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |